Neudle.com: dementia senile

Differential
(Click to cross reference)

abiotrophy

abstract reasoning

acalculia

acetylcholine

acetylcholine in CNS

acetylcholine receptor

acetylcholinesterase

acetyl-L-carnitine

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome dementia complex

acquired immunodeficiency syndrome, older adults

activities of daily living

activities of daily living scale

aducanumab

advance directives

advances in neurology

adverse drug reaction

age associated memory impairment

alcohol, neurologic complications with

Alzheimer's disease associated protein

Alzheimer's disease, age of onset

Alzheimer's disease, behavioral symptoms

Alzheimer's disease, conjugal

Alzheimer's disease, diagnosis of

Alzheimer's disease, driving with

Alzheimer's disease, early onset

Alzheimer's disease, early symptoms

Alzheimer's disease, familial

Alzheimer's disease, familial, late onset

Alzheimer's disease, heterogeneity of

Alzheimer's disease, incidence

Alzheimer's disease, misdiagnosis

Alzheimer's disease, noncognitive symptoms

Alzheimer's disease, pathogenesis

Alzheimer's disease, patient awareness of

Alzheimer's disease, preclinical

Alzheimer's disease, prognosis of

Alzheimer's disease, rapidly progressive

Alzheimer's disease, rate of clinical decline

Alzheimer's disease, risk factors in

Alzheimer's disease, staging

Alzheimer's disease, telling patient diagnosis of

Alzheimer's disease, treating associated medical problems in

Alzheimer's disease, treatment of

Alzheimer's disease, vaccine

Alzheimer's disease, visual variant

amnesia

amygdala

amyloid

amyloid angiopathy, cerebral

amyloid beta protein

amyloid beta protein antibodies

amyloid-related imaging abnormalities

amyotrophic lateral sclerosis

anatomy of

aneuploidy

aneurysm, intracranial, familial

angiotensin II receptor blocker

anticholinergic drugs

anticholinesterase

anticoagulant, treatment

aphasia, logopenic, progressive

aphasia, progressive

aphasia, progressive, primary

aphasia, transcortical

aphasia, transcortical-sensory

apnea

apolipoprotein E

apolipoprotein E, false positive

apoliprotein E, plasma level

apraxia, constructional

autonomic dysfunction

Balint's syndrome

basilar artery migraine

behavior

behavior modification

behavior, combative

behavioral disorder

benign essential tremor

benign senescent forgetfulness

benzodiazepine

beta adrenergic blocker

bovine spongiform encephalopathy

brain biopsy, complications of

brain biopsy, false negative

brain biopsy, indication

brain transplantation

burst suppression pattern, electroencephalogram

cardiac arrest and resuscitation

caregiver

carotid artery stenosis

CAT scan, emission, abnormal

CAT scan, false negative

CAT scan, indications for

CAT scan, normal ventricular size with aging

cell fusion test

central nervous system, infection of

cerebellar atrophy, primary

cerebellar atrophy, secondary

cerebellar degeneration

cerebellar plaques, amyloid

cerebral blood flow

cerebral cortical atrophy

cerebral death

cerebral dominance

cerebral edema

cerebral edema, vasogenic

cerebral glucose metabolism

cerebral hemisphere left-right asymmetry

cerebral infarction

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, biochemical markers of CNS disease

cerebrospinal fluid, enzymes in

cerebrospinal fluid, hydroxyindoleacetic acid, 5(5-HIAA)

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, serotonin

cerebrovascular accident

cerebrovascular accident, multiple

cerebrovascular accident, recurrent

cerebrovascular accident, silent

cerebrovascular disease

Charles Bonnet's syndrome

chelation therapy

choline acetyltransferase

chromosomal abnormality

cingulate island sign

cinnarizine

cisternogram, radionuclide

citalopram

claustrophobia

clindamycin

Clinical Pathologic Conference(C.P.C.)

color vision, impaired

color vision, impaired, cerebral

comorbidities

competency

complications

comprehension, impaired

conflict of interest

confusion

congenital malformation

congenital malformation, non CNS

constipation

contraindications

controversies in neurology

corpus callosum

corpus callosum, atrophy of

corpus callosum, neoplasm of

cortical-basal ganglionic degeneration

corticotropin-releasing factor

degenerative diseases of CNS

dementia, age at onset

dementia, cerebrovascular disease causing

dementia, clinical diagnosis

dementia, diagnostic classification

dementia, diagnostic evaluation of

dementia, differential diagnosis of

dementia, driving with

dementia, early detection

dementia, familial

dementia, frontal lobe type

dementia, frontotemporal

dementia, incidence

dementia, mixed

dementia, posttraumatic

dementia, preexisting in stroke patient

dementia, presenile

dementia, prevalence of

dementia, prevention of

dementia, rapidly progressive

dementia, reversible

dementia, screening for

dementia, transmissible

dementia, treatment of

dementia, unknown etiology

denial of illness

deprenyl

depression

depth perception, impaired

differential diagnosis

dihydroepiandosterone

dimebon

disability rating scale, neurological

disability, neurological

disease modifying agents

dopamine beta hydroxylase

drug induced neurologic disorders

dysexecutive syndrome

dyskinesia, buccal lingual facial

dystonia, drug induced

dystonia, focal

dystonia, post traumatic

dystonia, treatment of

dystonic reaction, acute

electrocardiogram, abnormal

electroencephalogram

electroencephalogram, abnormalities of

electroencephalogram, focal delta activity

electroencephalogram, periodic complexes

electroencephalogram, spike activity

electromagnetic fields

electromyogram

electron microscopy

electronic monitoring

employment

encephalitis, viral

encephalopathy, anoxic

endocarditis, native-valve

enkephalins

enzyme inhibition

enzyme, defect

epidemiology of neurology

ethics in neurology

evidence-based research

evoked potentials

excitotoxin

executive dysfunction

exercise

expert witness, medical

fatal familial insomnia

fever

fibrinolytic agents, utilization

finger nose finger test

football neurologic injuries

fracture, long bone

Friedreich's ataxia

frontal lobe, anatomy and physiology

frontal lobe, atrophy

frontal lobe, behavior with disease of

frontal lobe, lesion of

frontal lobe, pathologic signs of

gastrostomy, percutaneous endoscopic

gaze palsy

gaze palsy, horizontal

genetic neurologic disorders

genetic screening

genetic testing

Gerstmann syndrome

Gerstmann-Straussler-Scheinker disease

Gilles de la Tourette syndrome

glioblastoma multiforme(astrocytoma Gr.III)

glioma

glutamic acid

GPS tracking

granulovacuolar degeneration

grasping

gray matter

hallucination

hallucination, auditory

hallucination, visual

hallucination, visual, benign

haloperidol

handedness

head injury

head injury, hydrocephalus following

hemianopia, homonymous

hemianopia, isolated homonymous

hemiparesis

hemorrhagic diathesis

hemosiderosis of CNS, superficial

hemosiderosis, subarachnoid

hepatitis

heralding manifestation

herbs

herpes simplex encephalitis

herpes simplex encephalitis, diagnosis of

histamine-2 receptor blockers

histochemistry

HMGcoA reductase inhibitors

hydrocephalus, normal pressure

hyperpyrexia, CNS disorder causing

hyperreflexia

hypertension

hypertension, cerebrovascular disease with

hypertropia

hyposmia

hypotension, systemic

hypoxia

hypoxic encephalopathy

iatrogenic neurologic disorders

imbalance, postural

immunization, neurologic complications with

immunoperoxidase staining

inappropriate behavior

inattention

inclusion bodies

inclusion bodies, eosinophilic cytoplasmic

inclusion bodies, intracytopasmic

inclusion bodies, location of

intellectual deterioration

interobserver agreement

intracerebral hemorrhage

intracerebral hemorrhage, small

intranasal medication

Jakob-Creutzfeldt disease

Jakob-Creutzfeldt disease, variant

Jakob-Creutzfeldt disease, young adult

judgement, impaired

Kluver-Bucy syndrome

kuru

laboratory values, normal

L-dopa, drug interactions with and side effects of

lecanemab

lecithin

left-right orientation

leukoencephalitis, acute necrotizing hemorrhagic

Lewy body

Lewy body disease, diffuse

life expectancy

life support, withdrawal of

lifestyle

limbic system

limbic-predominant age-related TDP-43 encephalopathy

line bisection task

lipid lowering agent

lipid storage disorder of CNS

lipoma of CNS

liver disease

liver function enzymes

lobar atrophy

locus ceruleus, lesion of

logopenia

lymphoma involving CNS

machine learning

managed care

manganese intoxication

manic-depressive

marital status

medical-legal aspects of neurology

medication withdrawal

Memory Impairment Screen

memory, defect of recent

memory, disorder, treatment of

memory, evaluation of

memory, impairment of

memory, impairment of, isolated

memory, impairment of, subjective

memory, recent

meningoencephalitis

menopause

mental status, evaluation of

metrifonate

microhemorrhage, intracerebral

microtubule

migraine

mild cognitive impairment

mild cognitive impairment converting to Alzheimer's disease

mimics

Mini Mental Status Examination

misdiagnosis

misdirection

misidentification

mitochondrial disease

molecular genetics

mongolism

monoamine oxidase inhibitors

monoclonal antibodies

movement disorder, drug induced

movement disorder, extrapyramidal

MRI

MRI, abnormal

MRI, CAT scan compared to

MRI, cerebrovascular disease

MRI, false negative

MRI, field strength, high

MRI, susceptibility weighted

MRI, volumetry

MRI, voxel-based morphometry

MRS

multiple sclerosis

multiple sclerosis, diagnosis of

multiple system atrophy

murder

muscarinic agonist

muscular dystrophy

muscular dystrophy, Duchenne

neoplasm, intracranial

neoplasm, primary intracerebral

neoplasm, primary of CNS

nerve conduction studies

nerve growth factor

neurofibrillary degeneration

neurofibromatosis 1

neurofibromatosis 2

neuroleptic

neuroleptic sensitivity

neuroleptic, atypical

neurologic complications of, systemic disease

neurologic consultation

neurologic disease

neurologic disease, diagnoses of

neurologic evaluation

neurologic examination

neurologic history

neurologic signs

neurologic symptoms

neuronal degeneration

neuronal loss

neuroophthalmology

neuropathology

neuropathology, brain

neuropathy

neuropathy, amyloid

neuroprotective agents

non-dominant hemisphere

nonsteroidal anti-inflammatory drug

nucleus basalis of Meynert

nursing home

nylidrin

obsessive-compulsive disorder

occupational neurologic disorders

olanzapine

old age, driving and

old age, neurology of

olfactory bulb

optic nerve, lesion of

optic neuropathy

orthostatic hypotension

parietal lobe, atrophy

parietal lobe, lesion of

parietal lobe, syndromes of

Parkinson disease

Parkinson disease, arteriosclerotic

Parkinson disease, dementia with

Parkinson disease, diagnosis

Parkinson disease, differential diagnosis of

Parkinson disease, drug induced

Parkinson disease, early symptoms

Parkinson disease, etiology of

Parkinson disease, familial

Parkinson disease, heterogeneity of

Parkinson disease, L-dopa nonresponsive

Parkinson disease, misdiagnosis

Parkinson disease, nonmotor problems of

Parkinson disease, pathogenesis of

Parkinson disease, presymptomatic detection

Parkinson disease, prognosis of

Parkinson disease, sensory symptoms in

Parkinson disease, surgical treatment of

Parkinson disease, treatment of

Parkinson disease, tremor, absence of

Parkinsonism multiple-system atrophy

Parkinsonism plus syndrome

Parkinsonism syndrome

paroxetine

PAS positive material in the brain

pathologic reflex

pathology

patient information and support

peduncular hallucinosis

peptides, brain

perihippocampal fissure

perimetry

perimetry, computerized

persistent vegetative state

persistent vegetative state, children

persistent vegetative state, etiology of

Pittsburgh Compound B

placebo

pleocytosis of cerebrospinal fluid

pneumoencephalogram(PEG)

pneumonia

polyneuropathy

posterior cerebral artery occlusion

posterior cortical atrophy

posterior leukoencephalopathy syndrome

postoperative neurologic complications

prevention of neurologic disorders

prion disease

progesterone

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

progressive supranuclear palsy

protein 14-3-3, cerebrospinal fluid

pseudobulbar palsy

pseudodementia

psychiatric disorder

psychiatric problems in neurologic disorders

psychological testing

psychological testing, neurologic problems

psychomotor retardation

psychosis

psychotic behavior

pupil

pupil, abnormality in neurologic disorders

pure autonomic failure

pursuit eye movements, abnormal

pyramidal tract dysfunction

rapidly progressing neurologic illness

reading

reading disorder, acquired

reading problem, causes of

recombinant DNA

recurrent

reduplicative paramnesia

reflex sympathetic dystrophy

release phenomena

REM sleep

REM sleep behavior disorder

repetitive questioning

research

retinal degeneration

retrocollis

reversible cerebral vasoconstrictive syndromes

rheumatoid arthritis, neurologic complications of

rhinorrhea, CSF

rigidity

risk factors

risk factors, modification

risk-benefit assessment

saccadic eye movements, abnormal

safety

salivation, excessive

seizure, diagnosis of

seizure, psychomotor-temporal lobe

seizure, risk factors for

seizure, surgical treatment of

selective serotonin reuptake inhibitors

serum alanine aminotransferase

sexual behavior, disorder of

shadowing

shared decision making

sildenafil

simultanagnosia

simvastatin

single photon emission computed tomography

single photon emission computed tomography, false negative

skin, biopsy

skin, lesions in neurologic disorders

sleep

sleep apnea

sleep pathology and physiology

smell

Smell Identification Test

snoring

snout reflex

sodium-glucoe cotransporter-2 inhibitors

speech disorder

speech, loss of

spinal cord, injury of

spinal muscular atrophy

spinocerebellar ataxia

spinocerebellar ataxia type 1

spongy degeneration of brain

staining reactions in neuropathology

startle myoclonus

statin therapy

stem cell transplantation

stereotyped behavior

steroid

steroid therapy, CNS treatment and complications with

stimulation, deep brain

stooped posture

stress, emotional

stridor

subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease

subarachnoid hemorrhage

temporal lobe, atrophy

temporal lobe, lesion

temporal lobe, lesion, bilateral

tetrahydroaminoacridine

tissue plasminogen activator, intravenous

tonic foot response

torticollis

torticollis, post traumatic

TRAILBLAZER-ALZ trial

trauma

trazodone

treatment of neurologic disorder

treatment, non-pharmacologic

TREM2 variants

tremor

tremor, post traumatic

tremor, resting

trifluoperazine

trinucleotide repeats

vaccination, neurologic complications with

vasodilating agents in treatment of cerebrovascular disease

velnacrine

ventricular enlargement

visual acuity, decreased

visual evoked response

visual field defect

visual field testing

visual fields

visual fields, constricted

visuospatial disturbance

vitamin E

vitamin supplementation

vitamin therapy

walking, difficulty with

white matter disease, periventricular

whites

word-finding difficulty

workup

WORLD spelling test

writing

Showing articles 250 to 300 of 2347 << Previous Next >>

Drugs for Alzheimer's Disease
BMJ 323:123-124, O'Brien,J.T . &Ballard,C.G., 2001

The Effect of Brain Atrophy on Cerebral Hypometabolism in the Visual Variant of Alzheimer Disease
Arch Neurol 58:480-486, Bokde,A.L.W.,et al, 2001

A 5-Month, Randomized, Placebo-controlled Trial of Galantamine in AD
Neurol 54:2269-2276, Tariot,P.N.,et al, 2000

Galantamine in AD
Neurol 54:2261-2268, Raskind,M.A.,et al, 2000

Immunization for Alzheimer's Disease: A Shot in the Arm or a Whiff?
Ann Neurol 48:553-555, Levey,A.I., 2000

Rivastigmine (Exelon) for Alzheimer's Disease
The Medical Letter 42:93-94, , 2000

The Value of Informant Versus Individual's Complaints of Memory Impairment in Early Dementia
Neurol 55:1724-1726, Carr,D.B.,et al, 2000

Efficacy of Rivastigmine in Dementia with Lewy Bodies: a Randomised, Double-blind, Placebo-controlled International Study
Lancet, 356:2031-2036,2024, McKeith,I.,et al, 2000

Might Olfactory Dysfunction be a Marker of Early Alzheimer's Disease?
Lancet 355:84-85, Burns,A., 2000

Estrogen for Alzheimer's Disease in Women, Randomized, Double-Blind, Placebo-Controlled Trial
Neurol 54:295-301, Henderson,V.W.,et al, 2000

An 80-Year-Old Man With Memory Loss
JAMA 283:1046-1053, Larson,E.B., 2000

Using Serial Registered Brain Magnetic Resonance Imaging to Measure Disease Progression in Alzheimer Disease
ArchNeurol 57:339-344, Fox,N.C.,et al, 2000

Diagnostic Accuracy of Dementia with Lewy Bodies
ArchNeurol 57:347-351, Hohl,U.,et al, 2000

Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease
JAMA 283:1007-1015,1055, Mulnar,R.A.,et al, 2000

Donepezil Therapy in Clinical Practice, A Randomized Crossover Study
Arch Neurol 57:94-99, Greenberg,S.M.,et al, 2000

Progression of Parkinsonian Signs in Alzheimer's Disease
Neurol 54:1284-1289, Wilson,R.S.,et al, 2000

Practice Parameter: Risk of Driving and Alzheimer's Disease (An Evidence-Based Review)
Neurol 54:2205-2211, Dubinsky,R.M.,et al, 2000

The Preclinical Phase of Alzheimer Disease
Arch Neurol 57:808-813, Elias,M.F.,et al, 2000

Reduced Prevalence of AD in Users of NSAIDs and H2 Receptor Antagonists
Neurol 54:2066-2071, Anthony,J.C.,et al, 2000

Smoking and Dementia in Male British Doctors: Prospective Study
BMJ 320:1097-1102,1087, Doll,R.,et al, 2000

Variability of the Mini-Mental State Examination in Dementia
Neurol 54:1538-1539, Doraiswamy,P.M.&Kaiser,L., 2000

Survival in End-Stage Dementia Following Acute Illness
JAMA 284: 47-52, 87, Morrison,R.S. & Siu,A.L., 2000

Treating Nondementia Illnesses in Patients With Dementia
JAMA 283:3230-3235, Brauner,D.J. et al, 2000

Patterns of Brain Activation in People at Risk for Alzheimer's Disease
NEJM 343:450-456,502, Bookheimer,S.Y. et al, 2000

Relation Between Cholinesterase Inhibitor and Pisa Syndrome
Lancet 355:2222, Kwak,Y.T. et al, 2000

Anti-Inflammatory Drugs Protect Against Alzheimer Disease at Low Doses
Arch Neurol 57:1586-1591, Broe,G.A.,et al, 2000

Treatment of Agitation in AD
Neurol 55:1271-1278,1247, Teri,L.,et al, 2000

Dementia with Lewy Bodies in a Neuropathologic Series of Suspected Creutzfeldt-Jakob Disease
Neurol 55:1401-1404, Haik,S.,et al, 2000

Sorting Out Sleep in Patients with Alzheimer's Disease
Lancet 354:2098-2099, Foley,D., 1999

Treatment of Alzheimer's Disease
NEJM 341:1670-1679, Mayeux,R.&Sano,M, 1999

Immunologic Treatment of Alzheimer's Disease
NEJM 341:1694-1695, Blass,J.P., 1999

Estrogen Use and Early Onset Alzheimer's Disease:A Population-Based Study
JNNP 67:779-781, Slooter,A.J.C.,et al, 1999

Functional Magnetic Resonance Imaging in Neuropsychiatry
BMJ 319:1551-1554, Longworth,C.,et al, 1999

Diagnosis, Management, and Treatment of Alzheimer Disease, A Guide for the Internist
Arch Int Med 159:789-798, Richards,S.S.&Hendrie,H.C., 1999

Medial Temporal Lobe Atrophy on MRI in Dementia with Lewy Bodies
Neurol 52:1153-1158, Barber,R.,et al, 1999

A Randomized Trial of Risperidone,Placebo,and Haloperidol for Behavioral Symptoms of Dementia
Neurol 53:946-955,899, DeDeyn,P.P.,et al, 1999

Clinical Benefits of Donepezil:Results from a Long-Term Phase III Extension Trial
Neurol 52:A174, Doody,R.S.,et al, 1999

Altered Brain Activation in Cognitively Intact Individuals at High Risk for Alzheimer's Disease
Neurol 53:1391-1396, Smith,C.D.,et al, 1999

Diagnosing Dementia with Lewy Bodies
Lancet 354:1227-1228, McKeith,I.G.,et al, 1999

Do We Have Drugs for Dementia? No
Arch Neurol 56:735-737, Pryse-Phillips,W., 1999

Do We Have a Treatment for Alzheimer Disease? Yes
Arch Neurol 56:738-739,735, Gauthier,S., 1999

Nuclear Medicine in Neurology and Psychiatry
Lancet 354:1107-1111, Costa,D.C.,et al, 1999

Screening for Dementia with the Memory Impairment Screen
Neurol 52:231-238,224, Buschke,H.,et al, 1999

Progressive Aphasia with Rapidly Progressive Dementia in a 49 Year Old Woman
JNNP 66:238-243, Greene,J.D.W.,et al,, 1999

Efficacy and Safety of Rivastigmine in Patients with Alzheimer's Disease:International Randomised Controlled
BMJ 318:633-640, 615, Rosler,M.,et al, 1999

Mild Cognitive Impairment, Clinical Characterization and Outcome
Arch Neurol 56:303-308, Petersen,R.C.,et al, 1999

Cost-Effectiveness of Donepezil in the Treatment of Mild or Moderate Alzheimer's Disease
Neurol 52:1138-1145,1115, Neumann,P,J.,et al, 1999

Serial Magnetic Resonance Imaging of Cerebral Atrophy in Preclinical Alzheimer's Disease
Lancet 353:2125, Fox,N.C.,et al, 1999

Variability in Annual Mini-Mental State Examination Score in Patients with Probable Alzheimer Disease
Arch Neurol 56:857-862, Clark,C.M.,et al, 1999

Molecular Basis of the Neurodegenerative Disorders
NEJM 340:1970-1980, Martin,J.B., 1999

Showing articles 250 to 300 of 2347 << Previous Next >>